Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese Infants

Pediatric Infectious Disease Journal

Volumn 33, Issue 3, 2014, Pages e81-e86

  Chang, Wan Chi ^a   Yen, Catherine ^b   Wu, Fang Tzy ^c   Huang, Yhu Chering ^d   Lin, Jen Shiou ^e   Huang, Fu Chen ^d   Yu, Hui Tzu ^a   Chi, Cheng Liang ^a   Lin, Han Ying ^a   Tate, Jacqueline E ^b   Parashar, Umesh D ^b   Wu, Ho Sheng ^c,f   Hsiung, Chao A ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Gastroenteritis; Rotavirus; Rotavirus vaccine; Vaccine effectiveness

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE; RIX4414 VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; CASE CONTROL STUDY; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS INFECTION; TAIWAN; TAIWANESE; VACCINATION; CLASSIFICATION; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PRESCHOOL CHILD; ROTAVIRUS INFECTIONS; VIROLOGY;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TAIWAN; VACCINES, ATTENUATED;

EID: 84905856508     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000105     Document Type: Article

References (21)

1. P arashar UD, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009;200 (suppl 1): S9-S15.
2. P arashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565-572.
3. T ate JE, Burton AH, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirus-Associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-Analysis. Lancet Infect Dis. 2012;12:136-141.
4. C hen KT, Chen PY, Tang RB, et al. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. J Infect Dis. 2005;192 (suppl 1):S44-S48.
5. C hen SY, Chang YC, Lee YS, et al. Molecular epidemiology and clinical manifestations of viral gastroenteritis in hospitalized pediatric patients in Northern Taiwan. J Clin Microbiol. 2007;45:2054-2057.
6. Wu FT, Liang SY, Tsao KC, et al. Hospital-based surveillance and molecular epidemiology of rotavirus infection in Taiwan, 2005-2007. Vaccine. 2009;27 (suppl 5):F50-F54.
7. P hua KB, Lim FS, Lau YL, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine. 2009;27:5936-5941.
8. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
9. Vesikari T, Matson DO, Dennehy P, et al.; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent humanbovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354: 23-33.
10. Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010;125:e199-e207.
11. C orreia JB, Patel MM, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis. 2010;201:363-369.
12. de Palma O, Cruz L, Ramos H, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ. 2010;340:c2825.
13. Martinón-Torres F, Bouzón Alejandro M, Redondo Collazo L, et al.; ROTACOST research team. Effectiveness of rotavirus vaccination in Spain. Hum Vaccin. 2011;7:757-761.
14. P atel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA. 2009;301:2243-2251.
15. Wu TC, Liu HH, Chen YJ, et al. Comparison of clinical features of childhood norovirus and rotavirus gastroenteritis in Taiwan. J Chin Med Assoc. 2008;71:566-570.
16. Kawamura N, Tokoeda Y, Oshima M, et al. Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life. Vaccine. 2011;29:6335-6341.
17. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370:1757-1763.
18. Vesikari T, Karvonen A, Ferrante SA, Ciarlet M. Efficacy of the pentavalent rotavirus vaccine, RotaTeq(R), in Finnish infants up to 3 years of age: the Finnish Extension Study. Eur J Pediatr. 2010;169:1379-1386.
19. C astilla J, Beristain X, Martínez-Artola V, et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine. 2012;30:539-543.
20. Boom JA, Tate JE, Sahni LC, et al. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J. 2010;29:1133-1135.
21. Cortese MM, Leblanc J, White KE, et al. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics. 2011;128:e1474-e1481.